Arcalyst

Why Regeneron Pharmaceuticals Has A Bright Future Ahead
Why Regeneron Pharmaceuticals Has A Bright Future Ahead
Seeking Alpha
Regeneron
Arcalyst
Eylea
Zaltrap
Flag link:
3 Drugs Approved, but Only 1 Matters
3 Drugs Approved, but Only 1 Matters
Motley Fool
FDA
drug approvals
Regeneron
Arcalyst
Eyelea
Novartis
Sanofi
Zaltrap
Flag link:
FDA rejects expanded use of Regeneron drug for gout
FDA rejects expanded use of Regeneron drug for gout
Reuters
Regeneron
gout
FDA
Arcalyst
Flag link:
Vivus, Onyx, Amarin Await Key Dates in July
Vivus, Onyx, Amarin Await Key Dates in July
Minyanville
Amarin
ONYX Pharmaceuticals
Vivus
Qnexa
AMR101
Arcalyst
Regeneron
Kyprolis
Salix
Relistor
Progenics Pharmaceuticals
Rayos
Roche
Lucentis
Horizon Pharma
Flag link:
Regeneron: FDA panel says no to Arcalyst for gout
Regeneron: FDA panel says no to Arcalyst for gout
Yahoo/AP
FDA
Arcalyst
gout
Regeneron
Flag link:
Pfizer, Gilead Sciences, Arena Pharmaceuticals Face Big Dates in May
Pfizer, Gilead Sciences, Arena Pharmaceuticals Face Big Dates in May
Minyanville
Pfizer
Arena Pharmaceuticals
Gilead Sciences
Vyndaqel
JNJ
Xarelto
ASCO
Talon Therapeutics
Marqibo
Quad
Truvada
lorcaserin
Protalix BioTherapeutics
Alexza
Adasuve
Arcalyst
Regeneron
Abbott Laboratories
Remicade
Flag link:
6 Biotech Stocks With Huge Potential In May
6 Biotech Stocks With Huge Potential In May
Seeking Alpha
taliglucerase alfa
Protalix BioTherapeutics
Alexza
Adasuve
Regeneron
Arcalyst
lorcaserin
Arena Pharmaceuticals
Quad
Truvada
Gilead
Talon Therapeutics
Marqibo
Flag link:
Regeneron Announces Strong Results In Gout Study
Regeneron Announces Strong Results In Gout Study
Forbes
gout
Regeneron
Arcalyst
Flag link:
The Drug Passed, but the Stock Fell?
The Drug Passed, but the Stock Fell?
Motley Fool
Regeneron
gout
Arcalyst
Flag link: